At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Mepilex border post. op +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Multi-centre, Post CE-mark, Open Investigation to Evaluate the Performance of a Flexible Self-adherent Absorbent Dressing Coated With a Soft Silicone Layer After Hip or Knee Arthroplasty
In Brief
A Phase 4 clinical trial evaluating Mepilex border post. op and Mepilex border post op for Hip or Knee Surgery. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The overall rationale for this study is to evaluate the clinical performance potential for Mepilex Border Post-Op in the ability to minimise the risk of blistering, maceration and less dressing change due to high absorption capacity. This study is a part of Post Market Clinical Follow-Up (PMCF).
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHip or Knee Surgery
CountriesGermany
Collaborators--
Timeline
Phase 4CompletedFinished
20132014201520162017201820192020202120222023202420252026
Enrollment StartApr 2013
First PostedApr 2013
Primary CompletionSep 2013
TodayJul 2026
First PostedApr 26, 2013
Enrollment StartApr 1, 2013
Primary CompletionSep 1, 2013
TodayJul 2, 2026
Enrollment to primary: 5 monthsPosted 13.2 years ago
Interventions
Mepilex border post. opdevice
Mepilex border post opdevice